American Society of Hematology

SHERPA: Blue

People

  1. Levine
    Levine
  2. Giralt
    Giralt
  3. Devlin
    Devlin
  4. Perales
    Perales
  5. Abdel-Wahab
    Abdel-Wahab
  6. Landau
    Landau
  7. Van Den Brink
    Van Den Brink
  8. Moskowitz
    Moskowitz
  9. Hassoun
    Hassoun
  10. Horwitz
    Horwitz

Groups

  1. Center for Hematologic Malignancies (184)
  2. Department of Medicine (167)
  3. Hematologic Malignancies, Division of (165)
  4. GSK Faculty (71)
  5. Adult Leukemia (66)
  6. Executive Committee, Center for Hematologic Malignancies (56)
  7. Lymphoma (44)
  8. Bone Marrow Transplant (43)
  9. Human Oncology and Pathogenesis Program (43)
  10. Hematologic Malignancies Research (40)
Search Within
  1. "2015"
  2. "Center for Hematologic Malignancies"
  3. "Blood"
Formats
  1. Meeting Abstract (157)
  2. Journal Article (27)
Groups
  1. Center for Hematologic Malignancies (184)
  2. Department of Medicine (167)
  3. Hematologic Malignancies, Division of (165)
  4. GSK Faculty (71)
  5. Adult Leukemia (66)
  6. Executive Committee, Center for Hematologic Malignancies (56)

More Groups

People
  1. Martin Tallman (30)
  2. Ross Levine (26)
  3. Sergio Giralt (21)
  4. Sean Devlin (19)
  5. Carl Landgren (15)
  6. Craig Sauter (14)

More People

Years
  1. 2015 (184)
Publications
  1. Blood (184)

Results (184)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Does GVHD make amateurs out of professional APCs?
    Journal Article

    Hanash, A. M.
    Blood (2015)

    Fulltext@MSK | Save
  • Langerhans cells: Straight from blood to skin?
    Journal Article

    Romani, N.; Young, J. W.
    Blood (2015)

    Fulltext@MSK | Save
  • B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality
    Journal Article

    Veenstra, R. G.; Flynn, R.; Kreymborg, K.; McDonald-Hyman, C.; Saha, A.; Taylor, P. A.; Osborn, M. J.; Panoskaltsis-Mortari, A.; Schmitt-Graeff, A.; Lieberknecht, E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL
    Journal Article

    Appelmann, I.; Rillahan, C. D.; de Stanchina, E.; Carbonetti, G.; Chen, C.; Lowe, S. W.; Sherr, C. J.
    Blood (2015)

    Fulltext@MSK | Save
  • Success of online curriculum-based education in the management of multiple myeloma and continuing gaps among hematologists/oncologists
    Meeting Abstract

    Van Laar, E. S.; Landgren, O.
    Blood (2015)

    Fulltext@MSK | Save
  • Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era
    Meeting Abstract

    Vardhana, S. A.; Moskowitz, C. H.; Sauter, C. S.; Matasar, M. J.; Galasso, N.; Woo, K. M.; Zhang, Z. G.
    Blood (2015)

    Fulltext@MSK | Save
  • Distrust and conflict in sickle cell disease: Intersecting narratives of patients and physicians
    Meeting Abstract

    Tsyvkin, E.; Riessman, C.; Mathew, P.
    Blood (2015)

    Fulltext@MSK | Save
  • Phase 1 study of CB-839, a first-in-class, glutaminase inhibitor in patients with multiple myeloma and lymphoma
    Meeting Abstract

    Vogl, D. T.; Younes, A.; Stewart, K.; Orford, K. W.; Bennett, M.; Siegel, D.; Berdeja, J. G.
    Blood (2015)

    Fulltext@MSK | Save
  • SH2B3/LNK loss of function promotes atherosclerosis and thrombosis
    Meeting Abstract

    Wang, W.; Tang, Y.; Wang, Y.; Balcerek, J.; Tong, W.; Levine, R. L.; Welch, C.; Tall, A.; Wang, N.
    Blood (2015)

    Fulltext@MSK | Save
  • Refractory T-cell prolymphocytic leukemia with JAK3 mutation: In vitro and clinical synergy of tofacitinib and ruxolitinib
    Meeting Abstract

    Wei, M.; Koshy, N.; van Besien, K.; Inghirami, G.; Horwitz, S. M.
    Blood (2015)

    Fulltext@MSK | Save